OBJECTIVE: This study aimed to provide an up-to-date description as well as comparative
analysis of the national characteristics of pharmaceutical external price referencing (EPR) in …

China has been criticized for the long drug delay for a long time. There was little
understanding of Chinese drug lag formation from the investigational new drug (IND) …

This paper finds that the use of price controls has a statistically and quantitatively important
effect on the extent and timing of the launch of new drugs. Firms headquartered in countries …

Innovation is central to long-run economic growth. This chapter summarizes the state of the
literature on the economics of innovation, highlighting open policy questions. We first …

Abstract Analysis of the timing of launches of 642 new drugs in 76 countries during 1983–
2002 shows that patent and price regulation regimes strongly affect how quickly new drugs …

To what extent are firms kept out of a market by patents covering related technologies? Do
patents held by potential entrants make it easier to enter markets? We estimate the empirical …

Translating a diverse body of research, including industrial organization economics,
strategy, and entrepreneurship, we present a framework of micro entry—specifically, how de …

This paper examines the importance of geographical differentiation in store location
decisions of firms in the retail discount industry. Using a novel data set that includes the …

Innovation and marketing in the pharmaceutical industry International Series in Quantitative
Marketing Innovation and Marketing in the Pharmaceutical Industry Min Ding Jehoshua …

Localization of knowledge flows has been extensively examined in the literature on
innovation. However, almost all previous research has focused on technological knowledge …